Navigate Up
UPMC/University of Pittsburgh Schools of the Health Sciences

Patients and medical professionals may call 1-800-533-UPMC (8762) for more information.
 

Patients and medical professionals may call 1-800-533-UPMC (8762) for more information.
Thomas E. Starzl, M.D., Ph.D.

Thomas E. Starzl, M.D., Ph.D.
Biography

New Scientific Director Of Starzl Transplant Institute Plans New Research Program Using Jellyfish To Study Immune Tolerance

Extensive renovation of labs also being planned

PITTSBURGH, December 7, 2005 — At the helm as scientific director of the University of Pittsburgh’s Thomas E. Starzl Transplantation Institute for just three months, already, Fadi Lakkis, M.D., plans to develop a new program that will make use of a small marine animal in the jellyfish family as a model for studying the mechanisms of organ rejection and immune tolerance and will be renovating existing lab space in order to enhance communication among the institute’s various research groups. His plans reflect a new way of thinking, he says, that of “thinking outside of the box.”

Dr. Lakkis, who collaborates with Leo W. Buss, Ph.D., and Stephen Dellaporta, Ph.D., at his former institution, Yale University, is one of a small number of scientists working with jellyfish – which have no liver, kidneys or heart – to help gain understanding of organ transplantation’s immunological challenges.

As scientific director of the Starzl Transplantation Institute, Dr. Lakkis, who also is professor of surgery and immunology at the University of Pittsburgh School of Medicine, oversees Pitt’s internationally renowned transplant research program. While most of his work is focused on academic and research endeavors, including pursuit of his own studies, Dr. Lakkis, a nephrologist, also devotes a percentage of his time to clinical practice, managing the medical care of post-transplant kidney recipients at the University of Pittsburgh Medical Center .

“I came to the University of Pittsburgh in large part because of my utmost respect for the research faculty here and their important contributions to the field. And of course, Tom Starzl was a key reason, and I am honored to have the opportunity to carry on the legacy he has created and to help sustain the quality research for which this institution is known,” says Dr. Lakkis.

“My goals as scientific director are no different than those that have been at the core of the Starzl Transplant Institute. Specifically, I hope that we can better understand the process of and predictors for rejection, develop safe methods for inducing immune tolerance of transplanted organs and overcome the immunological barriers to successful xenotransplantation. But in order to achieve these goals we must think outside the box. It requires our collective talent, not individual teams working in silos. It necessitates tearing down any barriers, both figuratively and literally, that would otherwise impede cross communication and progress,” he explains.

Architectural plans have been drawn that would allow for an open design – similar to the innovative laboratory design inside the new Biomedical Science Tower 3 – that would accommodate more researchers than the existing floor plan and would facilitate unobstructed teamwork. Renovations of the space, located in Pitt’s first Biomedical Science Tower, will include room to house the small marine animal model that Dr. Lakkis will use for his research.

Dr. Lakkis officially joined the Starzl Transplant Institute on Sept. 1 from Yale University School of Medicine in New Haven, Conn., where he had been associate professor of medicine and immunobiology and director of transplant medicine since 2001. Prior to Yale, he was on the faculty of Emory University in Atlanta, from 1992 to 2001. He received the 1996 Young Investigator Award of the Transplantation Society, the 1999 Wyeth-Ayerst Young Investigator Award given by the American Society of Transplantation (AST), and in 2002, the Young Investigator Award of the American Society of Nephrology. That same year he was elected a member of the American Society of Clinical Investigation. From 2001 to 2004, he served a term as a councilor of the American Society of Transplantation.

He has contributed in many ways to the scientific literature and served as associate editor of the Journal of Immunology from 2000 to 2004.

The University of Pittsburgh’s Thomas E. Starzl Transplantation Institute is named in honor of transplant pioneer Thomas E. Starzl, M.D., Ph.D., who performed the world’s first liver transplant in 1963. The institute is world renowned for its cutting-edge research contributions and sheer volume of experience. Since 1981, nearly 12,000 transplants have been performed at the University of Pittsburgh, a single-center experience unmatched by any other program in the world.

©  UPMC | Affiliated with the University of Pittsburgh Schools of the Health Sciences
Supplemental content provided by A.D.A.M. Health Solutions. All rights reserved.

For help in finding a doctor or health service that suits your needs, call the UPMC Referral Service at 412-647-UPMC (8762) or 1-800-533-UPMC (8762). Select option 1.

UPMC is an equal opportunity employer. UPMC policy prohibits discrimination or harassment on the basis of race, color, religion, ancestry, national origin, age, sex, genetics, sexual orientation, marital status, familial status, disability, veteran status, or any other legally protected group status. Further, UPMC will continue to support and promote equal employment opportunity, human dignity, and racial, ethnic, and cultural diversity. This policy applies to admissions, employment, and access to and treatment in UPMC programs and activities. This commitment is made by UPMC in accordance with federal, state, and/or local laws and regulations.

Medical information made available on UPMC.com is not intended to be used as a substitute for professional medical advice, diagnosis, or treatment. You should not rely entirely on this information for your health care needs. Ask your own doctor or health care provider any specific medical questions that you have. Further, UPMC.com is not a tool to be used in the case of an emergency. If an emergency arises, you should seek appropriate emergency medical services.

For UPMC Mercy Patients: As a Catholic hospital, UPMC Mercy abides by the Ethical and Religious Directives for Catholic Health Care Services, as determined by the United States Conference of Catholic Bishops. As such, UPMC Mercy neither endorses nor provides medical practices and/or procedures that contradict the moral teachings of the Roman Catholic Church.

© UPMC
Pittsburgh, PA, USA UPMC.com